Asset 2Asset 2Asset 2Asset 2
  • Capabilities
    • Trial Design and Management
    • Data Management
    • Regulatory and Quality
    • Consulting and Program Management
    • Biospecimens and Logistics
  • Expertise
    • Trial Types
    • Health Innovation Solutions
    • Clinical Applications
  • About Us
    • Company
    • Management Team
  • News & Events
  • Contact
✕
            No results See all results
            • Filter by
            • Categories
            • Tags
            • Authors
            • Show all
            • All
            • Events
            • GBC Blog
            • In Vitro Diagnostics - IVD News
            • Press Releases
            • All
            • All
            • neil.mucci@globalbioclinical.com
            April 6, 2020
            Published by admin on April 6, 2020
            Categories
            • GBC Blog

            Emergency Use Application (EUA) Follows Completion of Test Validation with Patient Samples by Physician-Scientists at UC San Diego

            IRVINE, Calif., March 30, 2020 /PRNewswire/ — Fluxergy LLC, a research and medical diagnostic test company based in Irvine California, has submitted an Emergency Use Authorization (EUA) request to the […]
            Do you like it?0
            Read more
            April 1, 2020
            Published by admin on April 1, 2020
            Categories
            • GBC Blog

            Vela Diagnostics to Offer ViroKey™ SARS-CoV-2 RT-PCR Test After Completion of Emergency Use Authorization (EUA) Validation

            SINGAPORE, March 29, 2020 /PRNewswire/ — Ahead of Emergency Use Authorization (EUA) and in accordance with the U.S. Food and Drug Administration (FDA) Policy for Diagnostic […]
            Do you like it?0
            Read more
            April 1, 2020
            Published by admin on April 1, 2020
            Categories
            • In Vitro Diagnostics - IVD News

            Curetis and OpGen Complete Business Combination

            Amsterdam, The Netherlands, and Holzgerlingen, Germany, April 01, 2020, 10:00 pm CET – Curetis N.V. (in liquidation) (the “Company”) today announced that the business combination between […]
            Do you like it?0
            Read more
            April 1, 2020
            Published by admin on April 1, 2020
            Categories
            • GBC Blog

            Randox and Bosch to Launch Game-Changing Vivalytic Point of Care (POC) Coronavirus Test

            By HospiMedica International – 28 Mar 2020.Global diagnostics company Randox Laboratories (Crumlin, UK) and leading technology manufacturer Bosch Healthcare Solutions GmbH (Waiblingen, Germany) will launch a […]
            Do you like it?0
            Read more
            April 1, 2020
            Published by admin on April 1, 2020
            Categories
            • GBC Blog

            GenomicTree to Export COVID-19 Diagnostic Kit to USA

            GenomicTree said that it would start the shipment of its COVID-19 molecular diagnostic kit to Los Angeles, CA. Currently, the U.S. permits COVID-19 molecular diagnostic products […]
            Do you like it?0
            Read more
            March 31, 2020
            Published by admin on March 31, 2020
            Categories
            • GBC Blog

            Coronavirus Test Tracker: Commercially Available COVID-19 Diagnostic Tests

            MaAs labs and diagnostic developers race to meet demand for assays to detect the SARS-CoV-2 coronavirus, 360Dx is updating this tracker on a regular basis in […]
            Do you like it?0
            Read more
            March 30, 2020
            Published by admin on March 30, 2020
            Categories
            • In Vitro Diagnostics - IVD News

            OpGen Announces Shareholder Approval for Business Combination with Curetis

            GAITHERSBURG, Md., March 30, 2020 (GLOBE NEWSWIRE) — OpGen, Inc. (Nasdaq: OPGN, “OpGen”), a precision medicine company harnessing the power of molecular diagnostics and informatics to […]
            Do you like it?0
            Read more
            March 27, 2020
            Published by admin on March 27, 2020
            Categories
            • GBC Blog

            BioMérieux Receives Emergency Use Authorization for BIOFIRE® COVID-19 Test

            March 24, 2020 MARCY L’ÉTOILE, France–(BUSINESS WIRE)–Regulatory bioMérieux (Paris:BIM), a world leader in the field of in vitro diagnostics, today announced that its subsidiary, BioFire Defense, […]
            Do you like it?0
            Read more
            March 23, 2020
            Published by admin on March 23, 2020
            Categories
            • GBC Blog

            Researchers At UC San Diego Evaluating Potential “One-Hour” COVID-19 Diagnostic Test Developed By Irvine-Based Innovator Fluxergy

            IRVINE, Calif., March 17, 2020 /PRNewswire/ — Physician-scientists at the University of California, San Diego (UCSD) are the first to evaluate a new diagnostic testing system […]
            Do you like it?0
            Read more
            Prev page
            1234567891011121314151617181920212223242526272829303132333435
            Next page

            Global BioClinical
            600 1st Avenue, Suite 330 PMB 80042
            Seattle, WA 98104-2246 USA

            Tel: +1 888 659 1221
            Fax: +1 206 299 9895
            Email: info@globalbioclinical.com

            Capabilities

            Trial Design and Management

            Data Management

            Regulatory and Quality

            Consulting and Program Management

            Biospecimens and Logistics

            Expertise

            Trial Types

            Health Innovation Solutions

            Clinical Applications

            About Us

            Company

            Management Team

            News & Events

            Contact

            © 2025 Global BioClinical. All rights reserved. | Privacy Policy

                      No results See all results
                      ✕